Trial Profile
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluorine-18 ML 10 (Primary)
- Indications Brain metastases
- Focus Diagnostic use
- Sponsors Aposense
- 08 Apr 2014 New trial record